TY - JOUR
T1 - A comparison of DSM-5 and DSM-IV agoraphobia in the World Mental Health Surveys
AU - Roest, Annelieke M.
AU - de Vries, Ymkje Anna
AU - Lim, Carmen C. W.
AU - Wittchen, Hans-Ulrich
AU - Stein, Dan J.
AU - Adamowski, Tomasz
AU - Al-Hamzawi, Ali
AU - Bromet, Evelyn J.
AU - Viana, Maria Carmen
AU - de Girolamo, Giovanni
AU - Demyttenaere, Koen
AU - Florescu, Silvia
AU - Gureje, Oye
AU - Haro, Josep Maria
AU - Hu, Chiyi
AU - Karam, Elie G.
AU - Caldas-de-Almeida, José Miguel
AU - Kawakami, Norito
AU - Lépine, Jean Pierre
AU - Levinson, Daphna
AU - Medina-Mora, Maria E.
AU - Navarro-Mateu, Fernando
AU - O’Neill, Siobhan
AU - Piazza, Marina
AU - Posada-Villa, José A.
AU - Slade, Tim
AU - Torres, Yolanda
AU - Kessler, Ronald C.
AU - Scott, Kate M.
AU - de Jonge, Peter
AU - on behalf of the WHO World Mental Health Survey Collaborators
PY - 2019/6/1
Y1 - 2019/6/1
N2 - Background: The Diagnostic and Statistical Manual of Mental Disorders, version 5 (DSM-5) definition of agoraphobia (AG) as an independent diagnostic entity makes it timely to re-examine the epidemiology of AG. Study objective was to present representative data on the characteristics of individuals who meet DSM-IV criteria for AG (AG without a history of panic disorder [PD] and PD with AG) but not DSM-5 criteria, DSM-5 but not DSM-IV criteria, or both sets of criteria. Methods: Population-based surveys from the World Mental Health Survey Initiative including adult respondents (n = 136,357) from 27 countries across the world. The Composite International Diagnostic Interview was used to assess AG and other disorders. Results: Lifetime and 12-month prevalence estimates of DSM-5 AG (1.5% and 1.0%) were comparable to DSM-IV (1.4% and 0.9%). Of respondents meeting criteria in either system, 57.1% met criteria in both, while 24.2% met criteria for DSM-5 only and 18.8% for DSM-IV only. Severe role impairment due to AG was reported by a lower proportion of respondents who met criteria only for DSM-IV AG (30.4%) than those with both DSM-5 and DSM-IV AG (44.0%; χ 21 = 4.7; P = 0.031). The proportion of cases with any comorbidity was lower among respondents who met criteria only for DSM-IV AG (78.7%) than those who met both sets (92.9%; χ 21= 14.5; P < 0.001). Conclusions: This first large survey shows that, compared to the DSM-IV, the DSM-5 identifies a substantial group of new cases with AG, while the prevalence rate remains stable at 1.5%. Severity and comorbidity are higher in individuals meeting DSM-5 AG criteria compared with individuals meeting DSM-IV AG criteria only.
AB - Background: The Diagnostic and Statistical Manual of Mental Disorders, version 5 (DSM-5) definition of agoraphobia (AG) as an independent diagnostic entity makes it timely to re-examine the epidemiology of AG. Study objective was to present representative data on the characteristics of individuals who meet DSM-IV criteria for AG (AG without a history of panic disorder [PD] and PD with AG) but not DSM-5 criteria, DSM-5 but not DSM-IV criteria, or both sets of criteria. Methods: Population-based surveys from the World Mental Health Survey Initiative including adult respondents (n = 136,357) from 27 countries across the world. The Composite International Diagnostic Interview was used to assess AG and other disorders. Results: Lifetime and 12-month prevalence estimates of DSM-5 AG (1.5% and 1.0%) were comparable to DSM-IV (1.4% and 0.9%). Of respondents meeting criteria in either system, 57.1% met criteria in both, while 24.2% met criteria for DSM-5 only and 18.8% for DSM-IV only. Severe role impairment due to AG was reported by a lower proportion of respondents who met criteria only for DSM-IV AG (30.4%) than those with both DSM-5 and DSM-IV AG (44.0%; χ 21 = 4.7; P = 0.031). The proportion of cases with any comorbidity was lower among respondents who met criteria only for DSM-IV AG (78.7%) than those who met both sets (92.9%; χ 21= 14.5; P < 0.001). Conclusions: This first large survey shows that, compared to the DSM-IV, the DSM-5 identifies a substantial group of new cases with AG, while the prevalence rate remains stable at 1.5%. Severity and comorbidity are higher in individuals meeting DSM-5 AG criteria compared with individuals meeting DSM-IV AG criteria only.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85061342511&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30726581
U2 - 10.1002/da.22885
DO - 10.1002/da.22885
M3 - Article
C2 - 30726581
VL - 36
SP - 499
EP - 510
JO - Depression and Anxiety
JF - Depression and Anxiety
SN - 1091-4269
IS - 6
ER -